Condition
Phenylketonuria (PKU) clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Phenylketonuria (PKU) clinical trials that are recruiting, at sites in 9 countries (most in United States (4), France (2), Germany (1)). By phase: Phase 3 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 9Countries
Newest Phenylketonuria (PKU) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How often to check phenylalanine in adults with classic PKU | — | Krakow | Recruiting | Sep 17, 2026 |
| MZE782 in adults with phenylketonuria (PKU) testing safety and efficacy | Phase 2 | Oakland, California and 8 other locations | Recruiting | Jul 10, 2026 |
| PL54 injection safety in adults with PKU | Phase 1 | Hefei, Anhui | Recruiting | Jun 29, 2026 |
| Multiomics (genome plus metabolome) approach for adults with phenylketonuria | — | Angers and 14 other locations | Recruiting | Mar 20, 2026 |
| Investigating brain aging in adults with phenylketonuria | — | Bern | Recruiting | May 13, 2025 |
| Long-term JNT-517 treatment for people with phenylketonuria | Phase 3 | Gainesville, Florida and 11 other locations | Recruiting | Oct 4, 2024 |
| Long-term evaluation of immune response in PKU patients receiving Palynziq | — | Aurora, Colorado and 10 other locations | Recruiting | Mar 12, 2024 |
| Long-term safety assessment of pegvaliase in patients with PKU | — | Aurora, Colorado and 25 other locations | Recruiting | Apr 14, 2023 |
All recruiting trials (8)
-
How often to check phenylalanine in adults with classic PKU
This study tests whether checking phenylalanine levels weekly instead of monthly helps adults with classic PKU keep their levels under better control.
-
MZE782 in adults with phenylketonuria (PKU) testing safety and efficacy
This study tests whether MZE782 works safely for adults with PKU compared with a placebo.
-
PL54 injection safety in adults with PKU
This study tests whether PL54 is safe and tolerable when given once or in multiple weekly shots to adults with phenylketonuria.
-
Multiomics (genome plus metabolome) approach for adults with phenylketonuria
This project will test whether combining whole-genome sequencing from saliva and non-targeted blood metabolomics can find genetic and metabolic patterns linked to symptoms in adults who were treated for phenylketonuria from birth.
-
Investigating brain aging in adults with phenylketonuria
This study looks at how living with phenylketonuria (PKU) affects brain aging and thinking skills in adults who have followed a special diet since they were babies.
-
Long-term JNT-517 treatment for people with phenylketonuria
This trial tests the long-term safety of JNT-517 in children and adults with PKU, including people who previously took JNT-517 and those who are new to the drug.
-
Long-term evaluation of immune response in PKU patients receiving Palynziq
This study is testing how well Palynziq works over 10 years for people with PKU by looking at their immune responses and overall health.
-
Long-term safety assessment of pegvaliase in patients with PKU
This study is testing the long-term safety of pegvaliase in people with PKU to see how well it works and if there are any side effects over time.
Quick answers
How many Phenylketonuria (PKU) clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (4 trials), France (2 trials), Germany (1 trial), Italy (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.